NEW YORK, April 24 – Yamanouchi pharmaceuticals, Japan's third-largest drug maker,  plans to spend 50 billion yen, or $411.8 million, on genomics in the next five years, Reuters reported from Japan on Tuesday.

This investment doubles the company’s recent genomics spending level of four to 5 billion yen in the past several years.  

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.